We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Idebenone
A synthetic short-chain analog of coenzyme Q10 designed to support mitochondrial electron transport and act as an antioxidant. Important context: it has almost entirely been studied as a prescription DRUG (approved for Leber hereditary optic neuropathy in the EU as Raxone), not as an OTC supplement — and even its drug trials are mixed, with several outright negative neurological endpoints.
What the evidence says
Most Idebenone studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 1992–2026 with a typical study size of 316 participants.
Based on 57 studies · 6 meta-analyses · 32 RCTs · 1,661 total participants
Confidence
High confidenceBy outcome
Scored low/Emerging because idebenone is studied as a prescription drug with mixed-to-null results: the pivotal LHON trial missed its primary endpoint, Friedreich ataxia trials were negative, and OTC supplement efficacy is unestablished.
52 rigorous studies
31 randomized trials · 7 meta-analyses · 21 systematic reviews
Our evidence rating for Idebenone is accountable to this entire body of rigorous research indexed in PubMed — not a hand-picked subset.
PubMed · as of Jul 2026
3 trials ongoing or recruiting · 22 completed on ClinicalTrials.gov
12 of the completed trials have posted results
Registered trials show research momentum for Idebenone, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Sep 2026
Idebenone is a synthetic, shorter-tailed analog of coenzyme Q10 that can shuttle electrons in the mitochondrial respiratory chain and scavenge free radicals, with the theoretical advantage of better water solubility and brain penetration than CoQ10.
Crucially, idebenone has been developed and studied primarily as a pharmaceutical, not a dietary supplement: it is approved in the EU (as Raxone) for Leber hereditary optic neuropathy (LHON), a mitochondrial cause of vision loss. The evidence base is genuinely mixed.
In LHON, the pivotal RHODOS randomized trial missed its primary visual-acuity endpoint, with benefit appearing only in a post-hoc subgroup of patients with discordant baseline vision.
In Friedreich ataxia, multiple randomized placebo-controlled trials found NO significant benefit on neurological function or cardiomyopathy. Older Alzheimer's-disease studies suggested modest cognitive benefit, but a later large US trial was negative.
So while the mitochondrial rationale is real, idebenone should be understood as a drug with mixed-to-null results on most endpoints — not a well-validated cognitive or vision supplement.
As a CoQ10 analog, idebenone can transfer electrons in the respiratory chain, theoretically supporting ATP production in dysfunctional mitochondria.
Scavenges free radicals and may reduce lipid peroxidation, with relatively good water solubility and CNS penetration versus CoQ10.
How Idebenone works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Use only under specialist/neuro-ophthalmology care — this is a prescription indication.
Not adequately studied — avoid.
Idebenone is metabolized via CYP3A4; strong inhibitors/inducers could alter its levels. Discuss with a clinician.
Tip: Take with food
Tip: Harmless; expected with the compound
Tip: Reduce dose
Idebenone has an evidence score of 3/10 — emerging evidence based on 23 indexed studies. A synthetic short-chain analog of coenzyme Q10 designed to support mitochondrial electron transport and act as an antioxidant. Important context: it has almost entirely been studied as a prescription DRUG (approved for Leber hereditary optic neuropathy in the EU as Raxone), not as an OTC supplement — and even its drug trials are mixed, with several outright negative neurological endpoints. Representative study: PMID 21788663.
The commonly studied dose of Idebenone is Drug trials used 900mg/day (LHON) up to ~2250mg/day (ataxia); no validated OTC supplement dose. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
The best time to take Idebenone is with meals. Take it with food. Absorption improves with food (fat); pharmaceutical regimens divide the dose across meals.
Idebenone is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are mild GI upset (nausea, diarrhea), reddish/orange discoloration of urine, headache. Use caution if any of these apply to you: Pregnancy/breastfeeding (not adequately studied); Known hypersensitivity to idebenone.
Smoking status: not checked. AREDS2 Formula: what these mean for you changes depending on whether you smoke or used to, and you have not told us. That check was skipped.
CoQ10
Likely helpsA lipid-soluble antioxidant central to mitochondrial energy production, with the strongest trial support for fertility/IVF outcomes and heart failure.
Alpha-GPC
Likely helpsCrosses the blood-brain barrier to fuel acetylcholine synthesis — supports focus, memory, and power output in athletes.
Alpha Lipoic Acid
Likely helpsUniversal antioxidant that works in both water and fat, supporting blood sugar control, nerve health, and cellular energy.
AREDS2 Formula
Mostly mechanism / observationalThe one supplement formula with randomised-trial evidence for slowing age-related macular degeneration — but only in people who already have intermediate AMD or advanced AMD in one eye. It does not prevent AMD, and it does not restore vision that has been lost. AREDS2's own contribution was to swap beta-carotene out, because beta-carotene raises lung cancer risk in smokers and former smokers.
Explore: Best supplements for Focus, Memory & MoodBest supplements for Body Health
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 57 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research